JPL Wealth Management’s Entrada Therapeutics TRDA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$20 Buy
+3
New +$21 ﹤0.01% 1597

Other funds holding TRDA

JPL Wealth Management's TRDA Position: Q3 2026 in Review

JPL Wealth Management opened a new position in Entrada Therapeutics (TRDA) in Q3 2026: 3 shares worth $20. The stake represents ﹤0.01% of the portfolio and ranks #1597 among its holdings.

132 funds tracked by Wall St. Rank hold TRDA as of Q3 2026.

  • JPL Wealth Management held 3 shares of Entrada Therapeutics worth $20 as of Q3 2026.
  • Entrada Therapeutics was a new JPL Wealth Management position in Q3 2026.
  • Entrada Therapeutics made up ﹤0.01% of JPL Wealth Management's portfolio in Q3 2026, its #1597 holding.
  • 132 funds tracked by Wall St. Rank held Entrada Therapeutics as of Q3 2026.

Based on JPL Wealth Management's 13F filing for Q3 2026, filed 13 Nov 2026.